Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma

Oncology Letters
Jong-Shiaw JinChih-Wei Hsu

Abstract

The expression of cyclin A, B1, D1 and E in gastric adenocarcinoma is known to be associated with clinical outcome. However, few studies have investigated the role of cyclin T1 and cyclin-dependent kinase 9 (CDK9) in gastric adenocarcinoma. Therefore, this study assessed the clinical significance of cyclin T1 and CDK9 expression in gastric adenocarcinoma. A total of 39 gastric adenocarcinoma patients received either radical total or distal gastrectomy in this study. Surgical tissue slides were stained with CDK9 and cyclin T1 antibodies, and immunohistochemistry scores and disease-free survival (DFS) rates were analyzed. Among the 19 patients with tumor-recurrent or distant metastasis, 16 were recorded as exhibiting low expression of cyclin T1. The remaining three patients exhibited high expression of the antibody. The results of patients with a higher T stage, N stage and tumor grade were less favorable. For patients with adenocarcinoma, the percentage of tissue slides stained with cyclin T1 was significantly higher than for those with normal stomach epithelia. The DFS rates of patients with low expression of cyclin T1 were significantly associated with poorer DFS rates. In conclusion, high expression of cyclin T1 is a favorabl...Continue Reading

References

Apr 16, 1998·Genes & Development·J PengD H Price
May 25, 2001·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A De LucaM G Paggi
Jun 30, 2001·The Journal of Biological Chemistry·S H Chao, D H Price
Aug 30, 2002·Journal of Cancer Research and Clinical Oncology·Mitsuhiro YasudaDaisuke Korenaga
Nov 15, 2002·Cancer Biology & Therapy·Giulia De Falco, Antonio Giordano
Dec 21, 2002·Journal of Cellular Physiology·Antonio De LucaMarco G Paggi
Jul 20, 2004·The Journal of Pathology·Cristiana BellanAntonio Giordano
Aug 7, 2004·The EMBO Journal·Motoaki SanoMichael D Schneider
Oct 30, 2004·Circulation Research·Motoaki Sano, Michael D Schneider
May 19, 2006·International Journal of Cancer. Journal International Du Cancer·Johanna MrenaAri Ristimäki
Mar 14, 2007·Journal of Cellular Physiology·Eleonora LeucciAntonio Giordano
Dec 6, 2008·Digestive Diseases and Sciences·Gregory KouraklisAlkiviadis Kostakis
Aug 18, 2010·Cell Cycle·Cristian MoiolaAdriana De Siervi
Oct 1, 2010·Annals of Surgical Oncology·Kay Washington
Mar 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manish A ShahDavid P Kelsen
Jun 11, 2014·World Journal of Gastroenterology : WJG·Felix BerlthStefan Moenig

❮ Previous
Next ❯

Citations

Sep 2, 2016·Endocrine-related Cancer·Muhammed H RahamanShudong Wang
Dec 19, 2020·European Journal of Medicinal Chemistry·Xiaqiu QiuJinlei Bian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.